Frontiers in Nutrition · Jul 1, 2026

Association between vitamin D deficiency and longitudinal risk of head and neck cancer: a multi-institutional retrospective study

By Chen IW, Weng HL, Pang YL et al.

BACKGROUND: Vitamin D is implicated in cancer biology through its regulation of cellular proliferation, apoptosis, and immune surveillance; however, evidence linking vitamin D deficiency (VDD) to head and neck cancer (HNC) risk remains limited by small sample sizes and inadequate control for confounders. METHODS: Using the TriNetX Global Collaborative Network, we conducted a retrospective cohort study comparing adults with laboratory-confirmed VDD (25-hydroxyvitamin D < 20 ng/mL) against controls (≥30 ng/mL). After applying the exclusion criteria and 1:1 propensity score matching, 108,010 patients per group were retained. In a separate exploratory dose-response analysis, patients with vitamin D insufficiency (20.0-29.9 ng/mL) were compared with the same sufficiency threshold (≥30 ng/mL). A 180-day landmark period was applied to mitigate reverse causation, with follow-up extending to 10 years. The primary outcome was incident HNC; the secondary outcomes included laryngeal, oral, and other HNC subtypes. Positive (osteoporotic fracture) and negative (appendicitis) control outcomes were assessed to evaluate internal validity. RESULTS: VDD was associated with a significantly higher risk of incident HNC (HR 1.56, 95% CI 1.43-1.70, p < 0.001). Consistent associations were observed across anatomical subtypes: laryngeal cancer (HR 1.72, p < 0.001), oral cancer (HR 1.53, p < 0.001), and other HNCs (HR 1.46, p < 0.001). Vitamin D insufficiency was examined separately in 140,247 matched pairs and was associated with a smaller increase in HNC risk than VDD (HR 1.21, p < 0.001), supporting a dose-response pattern. Control outcomes validated the study design, with osteoporotic fracture confirming the expected positive association (HR 1.58, p < 0.001) and appendicitis demonstrating no spurious signal (HR 1.06, p = 0.226). The association was prominent in patients aged >50 years but absent in younger adults (p for interaction <0.001). Sensitivity analyses with extended landmark periods and alternative cohort definitions yielded consistent results. CONCLUSION: In this observational study, VDD was significantly associated with an increased risk of HNC, with consistency across subtypes and a dose-response gradient. However, the observational design precludes causal inference, and residual confounding cannot be fully excluded. Prospective studies with detailed lifestyle data are needed to confirm these findings.

doi.org/10.3389/fnut.2026.1826071Open accessPubMed 42459800Populations

AgingResearch.News